109 related articles for article (PubMed ID: 36801151)
1. Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis.
Ganga A; Kim EJ; Mintzer GL; Adriance W; Wang R; Cholankeril G; Balkrishnan R; Somasundar PS
Eur J Surg Oncol; 2023 Jul; 49(7):1242-1249. PubMed ID: 36801151
[TBL] [Abstract][Full Text] [Related]
2. Disparities in Primary Spinal Osseous Malignant Bone Tumor Survival by Medicaid Status: A National Population-Based Risk Analysis.
Ganga A; Kim EJ; Lee JY; Leary OP; Sastry RA; Fridley JS; Chang KE; Niu T; Sullivan PZ; Somasundar PS; Gokaslan ZL
World Neurosurg; 2024 Jan; 181():e192-e202. PubMed ID: 37777175
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Uveal Melanoma 5-Year Survival Rates by Medicaid Status: A Nationwide Analysis.
Kim EJ; Lee JY; Ganga A; Barton A; Rana V; Araia E; Adriance W; Wang R; Somasundar P; Kim LA
Ophthalmic Epidemiol; 2023 Nov; ():1-7. PubMed ID: 37964586
[TBL] [Abstract][Full Text] [Related]
4. Disparities in hepatocellular carcinoma survival by Medicaid-status: A national population-based risk analysis.
Kim EJ; Ganga A; Lee JY; Zawadzki RS; Adriance W; Wang R; Cholankeril G; Somasundar PS
Eur J Surg Oncol; 2023 Apr; 49(4):794-801. PubMed ID: 36503726
[TBL] [Abstract][Full Text] [Related]
5. Impact of Prior Malignancy on Survival Outcomes of Stage IV Pancreatic Adenocarcinoma: SEER-Based Cohort.
Al-Husseini MJ; Saad AM; Turk T; Tabash MA; Abdel-Rahman O
J Gastrointest Cancer; 2019 Dec; 50(4):794-800. PubMed ID: 30105523
[TBL] [Abstract][Full Text] [Related]
6. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
Smartt AA; Jang ES; Tyler WK
Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, Treatment, and Outcome of Pancreatic Squamous Cell Carcinoma and Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis Based on SEER-Database.
Wang Y; Zhou Y; Chen Y; Xia R; Liu J
Technol Cancer Res Treat; 2022; 21():15330338221106533. PubMed ID: 35770310
[No Abstract] [Full Text] [Related]
8. Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis.
Amin S; Lucas AL; Frucht H
Pancreas; 2013 Mar; 42(2):249-53. PubMed ID: 22836862
[TBL] [Abstract][Full Text] [Related]
9. From street address to survival: Neighborhood socioeconomic status and pancreatic cancer outcomes.
Eskander MF; Hamad A; Li Y; Fisher JL; Oppong B; Obeng-Gyasi S; Tsung A
Surgery; 2022 Mar; 171(3):770-776. PubMed ID: 34876291
[TBL] [Abstract][Full Text] [Related]
10. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
[TBL] [Abstract][Full Text] [Related]
11. Impact of Race, Insurance Status, and Primary Language on Presentation, Treatment, and Outcomes of Patients with Pancreatic Adenocarcinoma at a Safety-Net Hospital.
Sridhar P; Misir P; Kwak H; deGeus SW; Drake FT; Cassidy MR; McAneny DA; Tseng JF; Sachs TE
J Am Coll Surg; 2019 Oct; 229(4):389-396. PubMed ID: 31212101
[TBL] [Abstract][Full Text] [Related]
12. Association of Medicaid Expansion With Mortality Disparity by Race and Ethnicity Among Patients With De Novo Stage IV Breast Cancer.
Malinowski C; Lei X; Zhao H; Giordano SH; Chavez-MacGregor M
JAMA Oncol; 2022 Jun; 8(6):863-870. PubMed ID: 35389432
[TBL] [Abstract][Full Text] [Related]
13. Association of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes: Evidence from the National Cancer Database.
Fonseca AL; Cherla D; Kothari AN; Tzeng CD; Heslin MJ; Mehari KR; Johnston FM; Tran-Cao HS
Ann Surg Oncol; 2022 Jan; 29(1):342-351. PubMed ID: 34453259
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.
Murphy MM; Simons JP; Hill JS; McDade TP; Chau Ng S; Whalen GF; Shah SA; Harrison LH; Tseng JF
Cancer; 2009 Sep; 115(17):3979-90. PubMed ID: 19514091
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
[TBL] [Abstract][Full Text] [Related]
16. Insurance status is related to overall survival in patients with small intestine adenocarcinoma: A population-based study.
Wang N; Bu Q; Yang J; Liu Q; He H; Liu J; Ren X; Lyu J
Curr Probl Cancer; 2020 Feb; 44(1):100505. PubMed ID: 31548047
[TBL] [Abstract][Full Text] [Related]
17. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California.
Zell JA; Rhee JM; Ziogas A; Lipkin SM; Anton-Culver H
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):546-52. PubMed ID: 17372250
[TBL] [Abstract][Full Text] [Related]
18. Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity.
Swords DS; Mulvihill SJ; Brooke BS; Skarda DE; Firpo MA; Scaife CL
Surgery; 2019 Apr; 165(4):751-759. PubMed ID: 30551868
[TBL] [Abstract][Full Text] [Related]
19. Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status.
Walker GV; Grant SR; Guadagnolo BA; Hoffman KE; Smith BD; Koshy M; Allen PK; Mahmood U
J Clin Oncol; 2014 Oct; 32(28):3118-25. PubMed ID: 25092774
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an individualized nomogram for predicting pancreatic adenocarcinoma-specific survival: a SEER population analysis of 5,805 patients.
Liu JH; Wang SF; Li BR; Zhu X
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10483-10495. PubMed ID: 33155204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
